A new Beginning..., page-2375

In 2016 RAP share price was over 50 cents on hype.
RAP is months away toward a most probable CE Mark approval and probable commercialization and maybe not far away from FDA approval.

And the doctors who were in disagreement over 30% of the time in the US SMARTCOUGH-C2 study were not just doctors they were Pediatric Specialists in Respiratory illness from three of the most prestigious children's hospitals on the planet.

All IMO and in RAP announcements.

MB